What is iovera°?
iovera° offers a non-opioid pain relief treatment that utilizes cryoneurolysis technology to provide targeted, drug-free relief for conditions such as osteoarthritis and post-surgery recovery. The treatment is FDA-cleared and can be administered in various healthcare settings, including hospitals and outpatient clinics. iovera is designed for patients experiencing knee pain, as well as pain in other areas like the hip, shoulder, and spine. The system works by applying extreme cold to peripheral nerves, blocking pain signals for up to 90 days. This approach positions iovera° as a key player in the evolving landscape of pain management, offering an alternative to traditional pharmaceutical interventions.
How much funding has iovera° raised?
iovera° has raised a total of $72.6M across 6 funding rounds:
Debt
$2.2M
Private Equity
$18.8M
Private Equity
$32.7M
Private Equity
$10M
Debt
$8.4M
Unspecified
$556K
Debt (2010): $2.2M, investors not publicly disclosed
Private Equity (2011): $18.8M, investors not publicly disclosed
Private Equity (2012): $32.7M supported by DeNovo Ventures, Saratoga Ventures, L.P., Medicis Capital, and Accuitive Medical Ventures
Private Equity (2013): $10M featuring Medicis Capital Group, Accuitive Medical Ventures, Valiance Asset Management Limited, and DeNovo Ventures
Debt (2014): $8.4M backed by NMT Capital
Unspecified (2017): $556K, investors not publicly disclosed
Key Investors in iovera°
NMT Capital
NMT Capital is a globally oriented private equity firm managing investment funds in Europe and the US, with a portfolio that includes companies in North America and Europe at various stages of development. The firm leverages its deep industry knowledge to consult for global investment banks, helping them source and evaluate private medical companies in need of acquirers, strategic partners, or growth capital.
Medicis Capital Group
MEDICIS provides strategic and operational expertise in the healthcare sector, focusing on midsized companies. The company specializes in Pharma, Biotech, MedTech, Diagnostics, and Healthcare Services, offering support for strategic growth plans in Western Europe.
Accuitive Medical Ventures
Accuitive Medical Ventures is a venture capital firm with committed capital of $230 million. We have offices in Atlanta, GA and Amelia Island, FL. We are a market driven firm looking for revolutionary medical device technology investment opportunities.
What's next for iovera°?
With substantial backing and a major strategic investment, iovera° is poised for significant growth and market expansion. The company's focus on cryoneurolysis technology for drug-free pain relief aligns with increasing healthcare demands for effective, non-addictive treatment options. Future developments are likely to involve scaling manufacturing, expanding clinical applications, and broadening market penetration in both hospital and outpatient settings. The company's trajectory suggests a strong emphasis on research and development to further refine its therapeutic offerings and explore new indications for its innovative technology.
See full iovera° company page
